Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human herpesvirus 6: An emerging pathogen.

G Campadelli-Fiume1, P Mirandola, L Menotti

  • 1University of Bologna, Italy. campadel@kaiser.alma.unibo.it

Emerging Infectious Diseases
|May 26, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seeing to learn and learning to see: histology teaching between new technologies, old paradigms and natural cyborgs.

Advances in health sciences education : theory and practice·2025
Same author

Claimed effects, outcome variables and methods of measurement for health claims proposed under regulation (EC) 1924/2006 and related to cognitive function in adults.

Archives italiennes de biologie·2018
Same author

Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the framework of protection against oxidative damage and cardiovascular health.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2017
Same author

PKCε is a regulator of hypertrophic differentiation of chondrocytes in osteoarthritis.

Osteoarthritis and cartilage·2016
Same author

PKCε as a novel promoter of skeletal muscle differentiation and regeneration.

Experimental cell research·2015
Same author

Protein kinase Cɛ inhibition restores megakaryocytic differentiation of hematopoietic progenitors from primary myelofibrosis patients.

Leukemia·2015

Human herpesvirus 6 (HHV-6) is a widespread virus causing roseola in children. In immunocompromised individuals, HHV-6 reactivation can lead to severe opportunistic infections and potentially impact transplant outcomes.

Area of Science:

  • Virology
  • Immunology
  • Neuroscience

Background:

  • Human herpesvirus 6 (HHV-6), a beta-herpesvirus with two variants (A and B), exhibits near-universal seroprevalence.
  • Primary HHV-6B infection causes roseola infantum, a common childhood illness, with latent persistence in lymphocytes and monocytes.
  • HHV-6 is shed in saliva, with variant B transmission primarily occurring via this route.

Purpose of the Study:

  • To review the clinical significance of HHV-6 infections, particularly in immunocompromised populations.
  • To explore the potential correlation between HHV-6 and the pathogenesis of multiple sclerosis.
  • To discuss existing data supporting and refuting the HHV-6 and multiple sclerosis link.

Main Methods:

  • Literature review and synthesis of existing research on HHV-6.

Related Experiment Videos

  • Analysis of clinical data concerning HHV-6 in immunocompromised patients.
  • Examination of epidemiological and etiological studies investigating HHV-6 and multiple sclerosis.
  • Main Results:

    • HHV-6 is generally asymptomatic in immunocompetent individuals but poses a significant threat in immunosuppressed patients.
    • HHV-6 reactivation in transplant recipients can lead to graft rejection and mortality.
    • The association between HHV-6 and multiple sclerosis pathogenesis remains inconclusive, with conflicting evidence presented.

    Conclusions:

    • HHV-6 is a critical opportunistic pathogen in immunocompromised individuals, necessitating careful monitoring and management.
    • Further research is required to elucidate the role, if any, of HHV-6 in the development of multiple sclerosis.
    • Understanding HHV-6 epidemiology and pathogenesis is crucial for managing opportunistic infections and potentially neurological diseases.